Rapid recurrence of Helicobacter pylori infection in Peruvian patients after successful eradication

Clinical Infectious Diseases

Volumn 25, Issue 5, 1997, Pages 1027-1031

  Ramirez Ramos, Alberto ^c   Gilman, Robert H ^a   Leon Barua, Raul ^c   Recavarren Arce, Sixto ^c   Watanabe, Jose ^c   Salazar, Guillermo ^c   Checkley, William ^c   McDonald, Jeff ^c   Valdez, Yanet ^b   Cordero, Luis ^c   Carrazco, Juan ^c   Berendson, Robert ^b   Vasquez, Alicia ^b   Rodriguez, Carlos ^b   Miyagi, Juan ^b   Bonilla, Jose ^b   Alvarez, Maritza ^b   Gutierrez, Vilma ^b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BISMUTH SALICYLATE; FURAZOLIDONE; METRONIDAZOLE; PLACEBO; TETRACYCLINE; TINIDAZOLE;

ADOLESCENT; ADULT; BACTERIAL INFECTION; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVELOPING COUNTRY; DISEASE TRANSMISSION; FEMALE; GASTRITIS; GASTROINTESTINAL DISEASE; GASTROINTESTINAL ENDOSCOPY; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PEPTIC ULCER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT INFECTION; STOMACH CANCER; TREATMENT FAILURE;

EID: 20644462799     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/516083     Document Type: Conference Paper

References (30)

1. Nomura A, Stemmerman G, Chyou P, Kato I, Perez-Perez G, Blaser M. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 1991;325:1132-6.
2. Parsonnet J, Friedman G, Vandersteen D, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991;325:1127-31.
3. Dixon MF. Campylobacter pylori and chronic gastritis. In: Rathbone BJ, Heatley RV, eds. Campylobacter pylori and gastroduodenal disease. Oxford: Blackwell Scientific, 1989:106-16.
4. Recavarren-Arce S, Leon-Barua R, Cok J, et al. Helicobacter pylori and progressive gastric pathology that predisposes to gastric cancer. Scand J Gastroenterol Suppl 1991;181:51-7.
5. Leon-Barua R, Recavarren-Arce S, Gilman RH, Berendson R. Can eradication of Helicobacter pylori prevent gastric cancer? Drugs 1993;46:341-6.
6. Marshall BJ, McGechia DB, Rogers PA, Glancy RJ. Pyloric campylobacter infection and gastroduodenal disease. Med J Aust 1985;142:439-44.
7. Vigneri S, Savarino V, Termini R, Mela GS. Eradication of Helicobacter pylori in recurrent duodenal ulcer. N Engl J Med 1993;329:59-60.
8. Maaroos HI, Kekki M, Vorobjova T, Salupere V, Sipponen P. Risk of recurrence of gastric ulcer, chronic gastritis and grade of Helicobacter pylori colonization: a long-term follow-up study of 25 patients. Scand J Gastroenterol 1994;29:532-6.
9. Wotherspoon AC, Doglioni C, Diss TC, et al. Regression of primary lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993;342:575-7.
10. Thomas JE, Gibson GR, Darbee MK, Dale A, Weaver LT. Isolation of Helicobacter pylori from human faeces. Lancet 1993:340:1194-5.
11. Klein PD, The Gastrointestinal Physiology Working Group of Cayetano Heredia and the Johns Hopkins Universities, Graham DY, et al. Water source as risk factor for Helicobacter pylori infection in Peruvian children. Lancet 1991;337:1503-6.
12. Ramirez-Ramos A, Gilman R, Spira W, Recavarren S. Ecology of Helicobacter pylori in Peru: infection rates in coastal, high altitude, and jungle communities. Gut 1992;33:604-5.
13. Klein PD, Gilman RH, Leon-Barua R, Diaz F, Smith EO, Graham DY. The epidemiology of Helicobacter pylori in Peruvian children between 6 and 30 months of age. Am J Gastroenterol 1994;89:1296-200.
14. Bertram TA, Murray PD, Morgan DR, Jerdak G, Yang P, Czinn S. Gastritis associated with infection by Helicobacter pylori in humans: geographical differences. Scand J Gastroenterol Suppl 1991;181:1-8.
15. Hirschl AM, Pletschette M. Antibiotic treatment of Campylobacter pylori infection. In: Rathbone BJ, Heatley RV, eds. Campylobacter pylori and gastroduodenal disease. Oxford: Blackwell Scientific, 1989:217-24.
16. De Boer W, Driessen W, Arjan Jansz, Tytgat G. Effect of acid suppression on efficacy of treatment for Hp infection. Lancet 1995;345:817-20.
17. DeCross AJ, Marshall BJ, McCallum RW, Hoffman SR, Barren LJ, Guerran RL. Metronidazole susceptibility testing for Helicobacter pylori: comparison of disk, broth and agar dilution methods and their clinical relevance. J Clin Microbiol 1993;31:1971-4.
18. Glupczynski Y, Burrette A, DeKoster E, et al. Metronidazole resistance in Helicobacter pylori. Lancet 1990;335:539-40.
19. Vasquez A, Valdez Y, Gilman RH, et al. Metronidazole and clarithromycin resistance in Helicobacter pylori determined by minimum inhibitory concentrations of antimicrobials in color indicator egg yolk agar in a miniwell format. J Clin Microbiol 1996;34:1232-4.
20. Kuipers EJ, Pena AS, van-Kamp G, et al. Seroconversion for Helicobacter pylori. Lancet 1993;342:328-31.
21. Tygat GN, Noach LA, Rauws EA. Helicobacter pylori infection and duodenal ulcer disease. Gastroenterol Clin North Am 1993;22(1): 127-39.
22. Kosunen TU, Seppala K, Sarna S, Sipponen P. Diagnostic value of decreasing IgG, IgA, and IgM antibody titres after eradication of Helicobacter pylori. Lancet 1992;339:893-5.
23. Glupczynski Y, Burette A, Goossens H, DePrez C, Butzler JP. Effect of antimicrobial therapy on the specific serological response to Helicobacter pylori infection. Eur J Clin Microbjol Infect Dis 1992;11:583-8.
24. Gastrointestinal Physiology Working Group. Rapid identification of pyloric campylobacter in Peruvians with gastritis. Dig Dis Sci 1986;31:1089-94.
25. The Gastrointestinal Physiology Working Group of the Cayetano Heredia and The Johns Hopkins Universities, Morgan D, Kraft W, et al. Nitrofurans in the treatment of gastritis associated with Campylobacter pylori. Gastroenterology 1988;95:1178-84.
26. Korman MG, Marks IN, Hunt RH, et al. Helicobacter pylori: a workshop review. Eur J Gastroenterol Hepatol 1993;5:963-7.
27. Madico G, Verastegui M, the Gastrointestinal Physiology Working Group of Cayetano Heredia and the Johns Hopkins University. Serodiagnosis of Helicobacter pylori by enzyme-linked immunoelectrotransfer blot. J Diarrhoeal Dis Res 1995;13(2):122-6.
28. Brookmeyer R, Crowley J. A confidence interval for the median survival time. Biometrics 1992;38:29-41.
29. Cultler AF, Schubert TT. Long-term Helicobacter pylori recurrence after successful eradication with triple therapy. Am J Gastroenterol 1993;88:1359-61.
30. Seppala K, Farkkila M, Nuutinen H, et al. Triple therapy of Helicobacter pylori infection in peptic ulcer: a 12-month follow-up of 93 patients. Scand J Gastroenterol 1992;27:973-6.